Modelling of Systemic versus Pulmonary Chloroquine Exposure in Man for COVID-19 Dose Selection
View ORCID ProfileGhaith Aljayyoussi, View ORCID ProfileRajith KR Rajoli, Henry Pertinez, View ORCID ProfileShaun H Pennington, View ORCID ProfileW. David Hong, Paul M. O’Neill, Andrew Owen, View ORCID ProfileSteve A Ward, View ORCID ProfileGiancarlo A Biagini
doi: https://doi.org/10.1101/2020.04.24.20078741
Ghaith Aljayyoussi
1Centre for Drugs & Diagnostics, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, UK
Rajith KR Rajoli
2Department of Molecular and Clinical Pharmacology, Institute of Translational Medicine, University of Liverpool, Liverpool, UK
Henry Pertinez
2Department of Molecular and Clinical Pharmacology, Institute of Translational Medicine, University of Liverpool, Liverpool, UK
Shaun H Pennington
1Centre for Drugs & Diagnostics, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, UK
W. David Hong
3Department of Chemistry, University of Liverpool, Liverpool L69 7ZD
Paul M. O’Neill
3Department of Chemistry, University of Liverpool, Liverpool L69 7ZD
Andrew Owen
2Department of Molecular and Clinical Pharmacology, Institute of Translational Medicine, University of Liverpool, Liverpool, UK
Steve A Ward
1Centre for Drugs & Diagnostics, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, UK
Giancarlo A Biagini
1Centre for Drugs & Diagnostics, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, UK
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Article usage
Posted April 30, 2020.
Modelling of Systemic versus Pulmonary Chloroquine Exposure in Man for COVID-19 Dose Selection
Ghaith Aljayyoussi, Rajith KR Rajoli, Henry Pertinez, Shaun H Pennington, W. David Hong, Paul M. O’Neill, Andrew Owen, Steve A Ward, Giancarlo A Biagini
medRxiv 2020.04.24.20078741; doi: https://doi.org/10.1101/2020.04.24.20078741
Modelling of Systemic versus Pulmonary Chloroquine Exposure in Man for COVID-19 Dose Selection
Ghaith Aljayyoussi, Rajith KR Rajoli, Henry Pertinez, Shaun H Pennington, W. David Hong, Paul M. O’Neill, Andrew Owen, Steve A Ward, Giancarlo A Biagini
medRxiv 2020.04.24.20078741; doi: https://doi.org/10.1101/2020.04.24.20078741
Subject Area
Subject Areas
- Addiction Medicine (344)
- Allergy and Immunology (666)
- Anesthesia (181)
- Cardiovascular Medicine (2635)
- Dermatology (223)
- Emergency Medicine (398)
- Epidemiology (12205)
- Forensic Medicine (10)
- Gastroenterology (756)
- Genetic and Genomic Medicine (4079)
- Geriatric Medicine (387)
- Health Economics (679)
- Health Informatics (2636)
- Health Policy (1000)
- Hematology (362)
- HIV/AIDS (849)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (433)
- Neurology (3856)
- Nursing (209)
- Nutrition (573)
- Oncology (2015)
- Ophthalmology (584)
- Orthopedics (240)
- Otolaryngology (304)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (472)
- Pediatrics (1113)
- Primary Care Research (449)
- Public and Global Health (6509)
- Radiology and Imaging (1395)
- Respiratory Medicine (870)
- Rheumatology (402)
- Sports Medicine (342)
- Surgery (442)
- Toxicology (52)
- Transplantation (185)
- Urology (165)